EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Imaging‐Based Molecular Characterization of Adult‐Type Diffuse Glioma Using Diffusion and Perfusion MRI in Pre‐ and Post‐Treatment Stage Considering Spatial and Temporal Heterogeneity

Yun Hwa Roh, E-Nae Cheong, Ji Eun Park iD, Yangsean Choi iD, Seung Chai Jung, Sang Woo Song, Young-Hoon Kim, Chang-Ki Hong, Jeong Hoon Kim, Ho Sung Kim

Journal of Magnetic Resonance Imaging · 2025

DOI: 10.1002/jmri.29781 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Yun Hwa Roh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Glioma, Diffusion Magnetic Resonance Imaging, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Imaging‐based molecular characterization is important for identifying treatment targets in adult‐type diffuse gliomas.

Purpose

To assess isocitrate dehydrogenase (IDH) mutation and epidermal growth factor receptor (EGFR) amplification status in primary and recurrent gliomas using diffusion and perfusion MRI, addressing spatial and temporal heterogeneity. Study Type Retrospective. Subjects Three‐hundred and twelve newly diagnosed (cross‐sectional set, 57.9 ± 13.2 years, 52.2% male, 235 IDH‐wildtype, 71 EGFR‐amplified) and 38 recurrent (longitudinal set, 53.1 ± 13.4 years, 44.7% male, 30 IDH‐wildtype, 13 EGFR‐amplified) adult‐type diffuse glioma patients. Field Strength/Sequence 3.0T; diffusion weighted and dynamic susceptibility contrast‐perfusion weighted imaging. Assessment Radiomics features from contrast‐enhancing tumors (CET) and non‐enhancing lesions (NEL) were extracted from apparent diffusion coefficient and perfusion maps. Spatial heterogeneity was assessed using intersection and Bhattacharyya distance between CET and NEL. Stable imaging features were identified in patients with unchanged genetic profiles in the longitudinal set. The “best model,” using features from the cross‐sectional set ( n = 312), and the “concordant model,” using stable features identified in the longitudinal set ( n = 38), were constructed using the LASSO for IDH and EGFR status. Statistical Tests The area under the receiver‐operating‐characteristic curve (AUC).

Results

For IDH mutations, both best and concordant models demonstrated high AUCs in the cross‐sectional set (0.936; 95% confidence interval [CI]: 0.903–0.969 and 0.964 [0.943–0.986], respectively). Only the concordant model maintained strong performance in recurrent tumors (AUC, 0.919 vs. 0.656). For EGFR amplification in IDH‐wildtype, the best and concordant models showed AUCs of 0.821 (95% CI: 0.761–0.881) and 0.746 (95% CI: 0.675–0.817) in newly diagnosed gliomas, but poor performance in recurrent tumors with AUCs of 0.503 (95% CI: 0.34–0.665) and 0.518 (95% CI: 0.357–0.678). Data Conclusion Diffusion and perfusion MRI characterized IDH status in both newly diagnosed and recurrent gliomas, but showed limited diagnostic performance for EGFR, especially for recurrent tumors. Evidence Level 3 Technical Efficacy Stage 3

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaDiffusion Magnetic Resonance ImagingBrain NeoplasmsHumansMaleFemaleMiddle AgedRetrospective StudiesAdultIsocitrate DehydrogenaseCross-Sectional StudiesAgedErbB ReceptorsMutationBrainNeoplasm Recurrence, LocalPerfusion Magnetic Resonance Imaging

Stichwörter der Autor:innen

EGFRIDHcharacterizationgliomaheterogeneity

Substanzen

Isocitrate DehydrogenaseErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Department of Neurosurgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.

ORCID-Profile: Ji Eun Park, Yangsean Choi

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Roh, Y. H., Cheong, E. N., Park, J. E., Choi, Y., Jung, S. C., Song, S. W., Kim, Y. H., Hong, C. K., Kim, J. H., & Kim, H. S. (2025). Imaging‐Based Molecular Characterization of Adult‐Type Diffuse Glioma Using Diffusion and Perfusion MRI in Pre‐ and Post‐Treatment Stage Considering Spatial and Temporal Heterogeneity. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29781

Vancouver

Roh YH, Cheong EN, Park JE, Choi Y, Jung SC, Song SW, et al. Imaging‐Based Molecular Characterization of Adult‐Type Diffuse Glioma Using Diffusion and Perfusion MRI in Pre‐ and Post‐Treatment Stage Considering Spatial and Temporal Heterogeneity. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29781

BibTeX
@article{Roh2025,
  author = {Roh, Yun Hwa and Cheong, E-Nae and Park, Ji Eun and Choi, Yangsean and Jung, Seung Chai and Song, Sang Woo and Kim, Young-Hoon and Hong, Chang-Ki and Kim, Jeong Hoon and Kim, Ho Sung},
  title = {Imaging‐Based Molecular Characterization of Adult‐Type Diffuse Glioma Using Diffusion and Perfusion MRI in Pre‐ and Post‐Treatment Stage Considering Spatial and Temporal Heterogeneity},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  doi = {10.1002/jmri.29781}
}
Kostenlos starten →